Thoratec Corporation

Skip to content

VAD Trials & Outcomes

HeartMate II Clinical Results - Proven Long-Term Survival

HeartMate ll

After FDA approval for bridge-to-transplantation, a prospective clinical study was initiated to assess outcomes with the HeartMate II in a broader patient care environment. This is the first post-approval study utilizing the national Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).

Destination Therapy Results

Major clinical studies have shown HeartMate II to provide long-term survival that is more than two -times greater than the previous DT approved mechanical circulatory support device.27

REVIVEIT Study

A new trial to assess whether the use of a left ventricular assist device (LVAD) will improve survival compared to optimal medical management in advanced heart failure patients.

Text Size: A A A

See usage guidelines, research articles, and publications for Thoratec products.

Explore Resource Library